News Sentiment

HIMS sentiment intelligence

Hims Hers Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 52 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 34.38 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend active

-6.6% over one week, +28.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Hims & Hers Health Jumps 6.2% After B of A Securities Maintains Neutral

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 86/100 classification
One-week reaction -6.6% Price reacting lower
Trend fit Trend active 28.2% over four weeks
Fair value 30.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 35
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
simplywall.st 7
Market source 7
Investing.com 5
TradingView 5
Zacks 3
The National Law Review 3
Stock Traders Daily 2

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 4
Analyst action 3
Regulatory and legal 3
Deals and strategy 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 52
Stock Traders Daily Direct company coverage

Technical Reactions to HIMS Trends in Macro Strategies

This article analyzes Hims & Hers Health Inc. (NASDAQ: HIMS) using AI models to identify potential trading strategies. It highlights a strong near and mid-term positive sentiment, but a weak long-term outlook, and provides specific entry, target, and stop-loss levels for position

Tone
Negative 38/100
Event
Guidance
Published
07 Jul 2026 22:20
Source
Stock Traders Daily
Investing.com Direct company coverage

Hims & Hers CFO Okupe sells $261k in stock

Hims & Hers Health, Inc.'s CFO, Oluyemi Okupe, sold Class A Common Stock worth approximately $261,351 after exercising stock options. This transaction was part of a pre-arranged trading plan, and Okupe now directly holds 284,321 shares. The company has also seen positive analyst

Tone
Negative 41/100
Event
Analyst action
Published
07 Jul 2026 21:09
Source
Investing.com
Stock Titan Direct company coverage

Hims & Hers (NYSE: HIMS) CFO exercises options and sells 7,163 shares under 10b5-1 plan

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options for 7,163 shares at $5.01 per share and subsequently sold the same number of shares at an average price of $36.4863 per share. These transactions were carried out under a pre-established Rule 10b5-1 trading plan a

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:09
Source
Stock Titan
The National Law Review Direct company coverage

Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS) - Recover Losses - Contact Levi & Korsinsky Before August 25, 2025

A class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) alleging securities fraud between April 29, 2025, and June 23, 2025. The lawsuit claims Hims engaged in deceptive promotion of "knockoff" versions of Wegovy, risking termination of its collaboration wit

Tone
Negative 20/100
Event
Regulatory and legal
Published
01 Jul 2026 01:38
Source
The National Law Review
TradingView Direct company coverage

Hims & Hers Health, Inc. Class A Trade Ideas — SIX:HIMS.USD

This article compiles various trade ideas and analyses for Hims & Hers Health, Inc. (HIMS) stock, covering different perspectives from bullish long-term outlooks to cautious short-term setups. Key themes include the company's strong June performance, expansion into new markets an

Tone
Positive 68/100
Event
Market update
Published
30 Jun 2026 02:40
Source
TradingView
The National Law Review Direct company coverage

HIMS Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Shareholders of Securities Fraud Class Action Lawsuit Deadline

Kessler Topaz Meltzer & Check, LLP has issued a reminder to shareholders of Hims & Hers Health, Inc. (HIMS) about an ongoing securities fraud class action lawsuit. Investors who purchased HIMS securities between April 29, 2025, and June 23, 2025, are affected, and the lead plaint

Tone
Negative 28/100
Event
Regulatory and legal
Published
28 Jun 2026 01:09
Source
The National Law Review
The National Law Review Direct company coverage

Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025 - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action securities lawsuit against Hims & Hers Health, Inc. (NYSE:HIMS) for alleged securities fraud between April 29, 2025, and June 23, 2025. The lawsuit claims that Hims engaged in deceptive promotion of "knockoff" versions of Wegovy®, po

Tone
Negative 20/100
Event
Regulatory and legal
Published
27 Jun 2026 14:40
Source
The National Law Review
Stock Traders Daily Direct company coverage

Trading the Move, Not the Narrative: (HIMS) Edition

This article provides an AI-generated analysis for Hims & Hers Health Inc. (NASDAQ: HIMS), highlighting weak near-term sentiment but mid-term strength within a long-term weak bias. It details three distinct institutional trading strategies—Position Trading, Momentum Breakout, and

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 21:12
Source
Stock Traders Daily
TradingView Direct company coverage

Hims & Hers Health, Inc. Class A Actuals & Estimates (NYSE:HIMS)

This article provides an overview of Hims & Hers Health, Inc. (NYSE:HIMS) stock performance, financial actuals, and analyst estimates. It covers the current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings dates. The content also in

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 06:40
Source
TradingView
TradingView Direct company coverage

Price to book forward of Hims & Hers Health, Inc. Class A – XETR:82W

This article provides access to the "Price to book forward" financial metric for Hims & Hers Health, Inc. Class A (XETR:82W) on TradingView. It indicates that the market was closed at the time of publication and there were no trades. The content primarily directs users to various

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 21:40
Source
TradingView
Investing.com Direct company coverage

Hims & Hers CMO Patrick Carroll sells $830,410 in stock

Patrick Carroll, CMO of Hims & Hers Health, Inc., sold 23,726 shares of company stock for $830,410 on June 18, 2026. This transaction reduced his direct holdings to 181,861 shares of Class A Common Stock. The sale follows other company developments, including a raised price targe

Tone
Negative 40/100
Event
Market update
Published
24 Jun 2026 09:41
Source
Investing.com
Stock Titan Direct company coverage

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Hims & Hers Health, Inc. CFO Oluyemi Okupe reported stock option exercises and sales of common shares under a pre-arranged Rule 10b5-1 trading plan. Okupe exercised 6,376 shares of Class A common stock at $5.01 per share and sold 18,197 shares at an average price of $34.0285 per

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 22:41
Source
Stock Titan
Investing.com Canada Direct company coverage

Hims & Hers CFO Oluyemi Okupe sells $619,216 in shares By Investing.com

Hims & Hers Health, Inc.'s CFO, Oluyemi Okupe, sold 18,197 shares of Class A Common Stock for $619,216 on June 22, 2026, after exercising stock options. The sale was executed under a Rule 10b5-1 trading plan. This transaction follows other company developments, including a raised

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 22:41
Source
Investing.com Canada
Stock Titan Direct company coverage

Hims & Hers (NYSE: HIMS) CMO sells 23,726 shares, retains 181,861

Hims & Hers Health, Inc.'s Chief Medical Officer, Patrick Harrison, sold 23,726 shares of Class A Common Stock at $35.00 per share in an open-market transaction. Following this sale, Harrison still directly holds 181,861 shares of the company. The transaction is categorized as a

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 22:41
Source
Stock Titan